Health technologies (or healthtech) are one of the pillars of Luxembourg's economic diversification strategy launched in 2008. The strategic economic priorities are focused on medical devices, in vitro diagnostics and, more specifically, digital health in order to contribute to the implementation of preventive and personalised medicine at the national level.
In addition, the innovation strategy for the development of the sector is part of The Data-Driven Innovation Strategy for the Development of a Trusted and Sustainable Economy in Luxembourg. The health sector is listed among the "high-impact sectors" of Luxembourg's AI Strategy and "precision medicine" is listed among the "flagship projects" of the Luxembourg's Data Strategy (part of the "Accelerating digital sovereignty 2030" strategic initiative).
Luxembourg’s healthtech ambitions are closely aligned with the European Union’s priorities for strengthening health systems, fostering innovation in medical technologies and building a resilient European Health Union. Its compact size fosters collaboration between hospitals, research centres and startups.
The country is positioning itself as a hub for data-driven healthcare, personalised medicine and next-generation health solutions by leveraging its advanced research capabilities, secure digital infrastructure and strong collaborative networks. Cutting-edge data infrastructures, such as the Dataspace4Health, provide a trusted setting for secure health data use and clinical research.
In this context, Luxinnovation and the Ministry of Economy have developed a data-driven mapping in 2025. The scope of the healthtech ecosystem mapping includes private companies addressing with their technologies the needs of the human health market (e.g. from technologies to enable personalised medicine - such as wearable devices for patient remote monitoring to improve chronic disease management - to apps for mental health support). Activities of healthcare providers (e.g. doctors, dentists, prosthetists) and those of the public sector (e.g. public biomedical research, public hospitals, etc.) have been excluded.
